Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: Itraconazole-mediated changes on gastrointestinal disposition

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 3, 2007, Pages 242-248

  Ballent, M ^a,b   Lifschitz, A ^a,b   Virkel, G ^a,b   Sallovitz, J ^a   Lanusse, C ^a,b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; GLYCOPROTEIN P; ITRAC; ITRACONAZOLE; IVERMECTIN; IVOSINT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG POTENTIATION; FLUORESCENCE ANALYSIS; GASTROINTESTINAL MUCOSA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; JUGULAR VEIN; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; ANTIPARASITIC AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTESTINES; ITRACONAZOLE; IVERMECTIN; P-GLYCOPROTEIN; RUMEN; SHEEP;

ANIMALIA; OVIS ARIES;

EID: 34247591496     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00848.x     Document Type: Article

References (35)

1. Ali, D. Hennessy, D. (1996) The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep. Journal of Veterinary Pharmacology and Therapeutics, 19, 89 94.
2. Alvinerie, M., Sutra, J.F. Galtier, P. (1993) Ivermectin in goat milk after subcutaneous injection. Veterinary Research, 24, 417 421.
3. American Veterinary Medical Association (2001) Report of the AVMA. Panel on Euthanasia. Journal of the American Veterinary Medical Association, 218, 669 696.
4. Andrew, N. Halley, B. (1996) Stability of ivermectin in rumen fluids. Journal of Veterinary Pharmacology and Therapeutics, 19, 295 296.
5. Ballent, M., Lifschitz, A., Virkel, G., Sallovitz, J. Lanusse, C. (2006) Modulation of the p-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metabolism and Disposition, 34, 457 463.
6. Bogan, J. McKellar, Q. (1988) The pharmacodynamics of ivermectin in sheep and cattle. Journal of Veterinary Pharmacology and Therapeutics, 11, 260 268.
7. Borges, F., Silva, H., Buzzolini, C., Soares, V., Costa, A. Molento, M. (2005) Use of verapamil to increased anthelmintic efficacy of ivermectin against drug-selected strain of Haemonchus contortus. In Proceedings of the 20th International Conference of the World Association for the Advancement of Veterinary Parasitology, Christchurch, New Zealand, pp. 73. VetLearn Foundation, Palmerston North, New Zealand.
8. Borgsteede, F. (1993) The efficacy and persistent anthelmintic effect of ivermectin in sheep. Veterinary Parasitology, 50, 117 124.
9. Chiu, S.H.L., Green, M.L., Baylis, F.P., Eline, D., Rosegay, A., Meriwether, H. Jacob, T.A. (1990) Absorption tissue distribution and excretion of tritium-labelled ivermectin in cattle sheep and rats. Journal of Agricultural and Food Chemistry, 38, 2072 2078.
10. Cooper, K.J., Martin, P.D., Dane, A.L., Warwick, M.J., Schneck, D.W. Cantarini, M.V. (2003) Effect of itraconazole on the pharmacokinetics of rosuvastatin. Clinical Pharmacology and Therapeutics, 73, 322 329.
11. De Montigny, P., Shim, J.S. Pivnichny, J.V. (1990) Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent. Journal of Pharmaceutical and Biomedical Analysis, 8, 507 511.
12. Didier, A.D. Loor, F. (1996) The abamectin derivate ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs, 7, 745 751.
13. Dupuy, J., Larrieu, G., Sutra, J.F., Lespine, A. Alvinerie, M. (2003) Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology, 112, 337 347.
14. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics, 2nd edn, Revised and Expanded. Marcel Dekker Inc., New York, USA.
15. Hennessy, D.R., Page, S.W. Gottschall, D. (2000) The behaviour of doramectin in the gastrointestinal tract, its secretion in bile and pharmacokinetic disposition in the peripheral circulation after oral and intravenous administration to sheep. Journal of Veterinary Pharmacology and Therapeutics, 23, 203 213.
16. Imperiale, F., Lifschitz, A., Sallovitz, J., Virkel, G. Lanusse, C. (2004) Comparative depletion of ivermectin and moxidectin milk residues in dairy sheep after oral and subcutaneous administration. Journal of Dairy Research, 71, 427 433.
17. Laffont, C.M., Toutain, P., Alviniere, M. Bousquet-Mélou, A. (2002) Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metabolism and Disposition, 30, 626 630.
18. Lespine, A., Sutra, J.F., Dupuy, J., Alvinerie, M. Aumont, G. (2004) The influence of parasitism on the pharmacokinetics of moxidectin in lambs. Parasitology Research, 93, 121 126.
19. Lifschitz, A., Virkel, G., Imperiale, F., Sutra, J.F., Galtier, P., Lanusse, C. Alvinerie, M. (1999) Moxidectin in cattle: correlation between plasma and target tissues disposition kinetics. Journal of Veterinary Pharmacology and Therapeutics, 22, 266 273.
20. Lifschitz, A., Virkel, G., Sallovitz, J., Sutra, J.F., Galtier, P., Alvinerie, M. Lanusse, C. (2000) Comparative distribution of ivermectin and doramectin to tissues of parasitic location in cattle. Veterinary Parasitology, 87, 327 338.
21. Lifschitz, A., Virkel, G., Sallovitz, J., Imperiale, F., Pis, A. Lanusse, C. (2002) Loperamide-induced enhancement of moxidectin availability in cattle. Journal of Veterinary Pharmacology and Therapeutics, 25, 111 120.
22. Lifschitz, A., Virkel, G., Sallovitz, J., Imperiale, F., Pis, A. Lanusse, C. (2004) Loperamide modifies the tissue disposition kinetics of ivermectin in rats. Journal of Pharmacy and Pharmacology, 56, 61 67.
23. Lifschitz, A., Virkel, G., Ballent, M., Sallovitz, J., Pis, A. Lanusse, C. (2005) Moxidectin and ivermectin metabolic stability in sheep ruminal and abomasal contents. Journal of Veterinary Pharmacology and Therapeutics, 28, 411 418.
24. Lifschitz, A., Ballent, M., Virkel, G., Sallovitz, J. Lanusse, C. (2006) Sex-related differences on the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation. Journal of Pharmacy and Pharmacology, 58, 1055 1062.
25. Lin, J.H. (2003) Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Advanced Drug Delivery Reviews, 55, 53 81.
26. Marriner, S.E., McKinnon, I. Bogan, J.A. (1987) The pharmacokinetics of ivermectin after the oral and subcutaneous administration to sheep and horses. Journal of Veterinary Pharmacology and Therapeutics, 10, 175 179.
27. Molento, M., Lifschitz, A., Sallovitz, J., Lanusse, C. Prichard, R. (2004) Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep. Parasitology Research, 92, 121 127.
28. Poulliot, J.F., L'Heureux, F., Liu, Z., Prichard, R. Georges, E. (1997) Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochemical Pharmacology, 53, 17 25.
29. Prichard, R., Steel, J., Lacey, E. Hennesy, D. (1985) Pharmacokinetics of ivermectin in sheep following intravenous, intra-abomasal or intraruminal administration. Journal of Veterinary Pharmacology and Therapeutics, 8, 88 94.
30. Schinkel, A., Smit, J., van Telligen, O., Beijnen, J., Wagenaar, E., van Deemter, L., Mol, C., van der Valk, M., Rocabus-Maandag, E., Riele, H., Berns, A. Borst, P. (1994) Disruption of the mouse mdr1a P-Glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491 502.
31. Schinkel, A., Wagenaar, E., Mol, C. van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Journal of Clinical Investigation, 97, 2517 2524.
32. Shin, J., Choi, K., Kim, Y. Lee, M. (2004) Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect. Antimicrobial Agents and Chemotherapy, 48, 1756 1762.
33. Stephens, R.H., Tanianis-Hughes, N., Higgs, N.B., Humphrey, M. Warhust, G. (2002) Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a (-/-) mouse intestine. Journal of Pharmacology and Experimental Therapeutics, 303, 1095 1101.
34. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. Willingham, M.C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the United States of America, 84, 7735 7738.
35. Watkins, P.B. (1997) The barrier of CYP3A4 and P-glycoprotein in the small bowel. Advanced Drug Delivery Reviews, 27, 161 170.